Arkolith/Insider Trading/SUPN/Form 4

Horich William Todd

SVP, Commercial OperationsSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$484K
Net Open-Market Flow
-$484K
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)4K$55.00$244K0
Mar 9, 2026Sell(S)4K$54.00$240K4K
Mar 6, 2026Option exercise(M)1K—$09K
Mar 6, 2026Tax withholding(F)2K$54.73$94K8K
Mar 6, 2026Option exercise(M)4K—$010K
Mar 6, 2026Option exercise(M)3K—$07K
Mar 6, 2026Tax withholding(F)1K$54.73$67K6K
Mar 6, 2026Tax withholding(F)521$54.73$29K9K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)1K—$00
Mar 6, 2026Option exercise(M)3K—$00
Mar 6, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002117599-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML